Sarcopenia is common in patients with cirrhosis and unresectable HCC treated by transarterial embolization but is not associated with increased rates of complications
2020-01-01 Masetti, C; Pugliese, N; Messana, G; Ceriani, R; Poretti, D; Lleo, A; Lanza, E; Colombo, M; Personeni, N; Pedicini, V; Torzilli, G; Aghemo, A
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: a real-world study
2022-01-01 D'Alessio, Antonio; Fulgenzi, Claudia Angela Maria; Nishida, Naoshi; Schönlein, Martin; Von Felden, Johann; Schulze, Kornelius; Wege, Henning; Gaillard, Vincent E; Saeed, Anwaar; Wietharn, Brooke; Hildebrand, Hannah; Wu, Linda; Ang, Celina; Marron, Thomas U; Weinmann, Arndt; Galle, Peter R; Bettinger, Dominik; Bengsch, Bertram; Vogel, Arndt; Balcar, Lorenz; Scheiner, Bernhard; Lee, Pei-Chang; Huang, Yi-Hsiang; Amara, Suneetha; Muzaffar, Mahvish; Naqash, Abdul Rafeh; Cammarota, Antonella; Personeni, Nicola; Pressiani, Tiziana; Sharma, Rohini; Pinter, Matthias; Cortellini, Alessio; Kudo, Masatoshi; Rimassa, Lorenza; Pinato, David J
The role of hepatic metastases and pulmonary tumor burden in predicting survival after complete pulmonary resection for colorectal cancer
2013-01-01 Sclafani, F; Incarbone, M; Rimassa, L; Personeni, N; Giordano, L; Alloisio, M; Santoro, A
The immune milieu of cholangiocarcinoma: From molecular pathogenesis to precision medicine
2019-01-01 Rimassa, L; Personeni, N; Aghemo, A; Lleo, A
Molecular determinants of outcome in sorafenib-treated patients with hepatocellular carcinoma
2013-01-01 Personeni, N.; Rimassa, L.; Pressiani, T.; Destro, A.; Ligorio, C.; Tronconi, M. C.; Bozzarelli, S.; Carnaghi, C.; Di Tommaso, L.; Giordano, L.; Roncalli, M.; Santoro, A.
Cabozantinib for the treatment of hepatocellular carcinoma
2019-01-01 Personeni, N; Rimassa, L; Pressiani, T; Smiroldo, V; Santoro, A
Hepatic intra-arterial injection of Yttrium-loaded microspheres for liver metastasis secondary to colorectal cancer: best soups are sometimes made from old recipes
2006-01-01 A, Hendlisz; Personeni, N.; T, Delaunoit; S, Debroux; P., Flamen
Tivantinib for hepatocellular carcinoma
2015-01-01 Rimassa, L.; Personeni, N.; Santoro, A.
Emergence of KRAS-mutation in liver metastases after an anti-EGFR treatment in patient with colorectal cancer: Are we aware of the therapeutic impact of intratumor heterogeneity?
2018-01-01 Baretti, M; Personeni, N; Destro, A; Santoro, A; Rimassa, L
Regorafenib for the treatment of unresectable hepatocellular carcinoma
2017-01-01 Rimassa, L; Pressiani, T; Personeni, N; Santoro, A
Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications
2016-01-01 Personeni, N.; Baretti, M.; Bozzarelli, S.; Spaggiari, P.; Rubino, L.; Tronconi, M. C.; Fumagalli Romario, U.; Rosati, R.; Giordano, L.; Roncalli, M.; Santoro, A.; Rimassa, L.
FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression : a Phase II Study
2015-01-01 Personeni, N.; Rimassa, L.; Verusio, C.; Barni, S.; Rubino, L.; Bozzarelli, S.; Villa, E.; Carnaghi, C.; Tronconi, M. C.; Gerardi, C.; Galli, F.; Floriani, I.; Destro, A.; Raschioni, C.; Labianca, R.; Santoro, A.
Emergence of KRAS-mutation in liver metastases after an anti-EGFR treatment in patient with colorectal cancer: are we aware of the therapeutic impact of intratumor heterogeneity?
2018-01-01 Baretti, M; Personeni, N; Destro, A; Santoro, A; Rimassa, L
Achievements in systhemic therapies in the pre-genomic era in metastatic breast cancer
2007-01-01 M, Colozza; E, Azambuja; Personeni, N.; F, Lebrun; Mj, Piccart; F., Cardoso
OncoAlert round table discussions: The global COVID-19 experience
2021-01-01 Morgan, G; De Azambuja, E; Punie, K; Ades, F; Heinrich, K; Personeni, N; Rahme, R; Ferrara, R; Pels, K; Garassino, M; von Bergwelt-Baildon, M; Lopes, G; Barlesi, F; Choueiri, Tk; Burris, H; Peters, S
Regorafenib for the treatment of unresectable hepatocellular carcinoma
2017-01-01 Rimassa, L; Pressiani, T; Personeni, N; Santoro, A
Tivantinib: a new promising mesenchymal-epithelial transition factor inhibitor in the treatment of hepatocellular carcinoma
2013-01-01 Rimassa, L; Personeni, N; Simonelli, M; Santoro, A
Regorafenib in hepatocellular carcinoma: latest evidence and clinical implications
2018-01-01 Personeni, N; Pressiani, T; Santoro, A; Rimassa, L
SYSTEMIC TREATMENT OF HCC IN SPECIAL POPULATIONS
2021-01-01 Rimassa, Lorenza; Personeni, Nicola; Czauderna, Carolin; Foerster, Friedrich; Galle, Peter
Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study
2018-01-01 Baretti, M; Rimassa, L; Personeni, N; Giordano, L; Tronconi, Mc; Pressiani, T; Bozzarelli, S; Santoro, A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Sarcopenia is common in patients with cirrhosis and unresectable HCC treated by transarterial embolization but is not associated with increased rates of complications | 1-gen-2020 | Masetti, C; Pugliese, N; Messana, G; Ceriani, R; Poretti, D; Lleo, A; Lanza, E; Colombo, M; Personeni, N; Pedicini, V; Torzilli, G; Aghemo, A | |
| Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: a real-world study | 1-gen-2022 | D'Alessio, Antonio; Fulgenzi, Claudia Angela Maria; Nishida, Naoshi; Schönlein, Martin; Von Felden, Johann; Schulze, Kornelius; Wege, Henning; Gaillard, Vincent E; Saeed, Anwaar; Wietharn, Brooke; Hildebrand, Hannah; Wu, Linda; Ang, Celina; Marron, Thomas U; Weinmann, Arndt; Galle, Peter R; Bettinger, Dominik; Bengsch, Bertram; Vogel, Arndt; Balcar, Lorenz; Scheiner, Bernhard; Lee, Pei-Chang; Huang, Yi-Hsiang; Amara, Suneetha; Muzaffar, Mahvish; Naqash, Abdul Rafeh; Cammarota, Antonella; Personeni, Nicola; Pressiani, Tiziana; Sharma, Rohini; Pinter, Matthias; Cortellini, Alessio; Kudo, Masatoshi; Rimassa, Lorenza; Pinato, David J | |
| The role of hepatic metastases and pulmonary tumor burden in predicting survival after complete pulmonary resection for colorectal cancer | 1-gen-2013 | Sclafani, F; Incarbone, M; Rimassa, L; Personeni, N; Giordano, L; Alloisio, M; Santoro, A | |
| The immune milieu of cholangiocarcinoma: From molecular pathogenesis to precision medicine | 1-gen-2019 | Rimassa, L; Personeni, N; Aghemo, A; Lleo, A | |
| Molecular determinants of outcome in sorafenib-treated patients with hepatocellular carcinoma | 1-gen-2013 | Personeni, N.; Rimassa, L.; Pressiani, T.; Destro, A.; Ligorio, C.; Tronconi, M. C.; Bozzarelli, S.; Carnaghi, C.; Di Tommaso, L.; Giordano, L.; Roncalli, M.; Santoro, A. | |
| Cabozantinib for the treatment of hepatocellular carcinoma | 1-gen-2019 | Personeni, N; Rimassa, L; Pressiani, T; Smiroldo, V; Santoro, A | |
| Hepatic intra-arterial injection of Yttrium-loaded microspheres for liver metastasis secondary to colorectal cancer: best soups are sometimes made from old recipes | 1-gen-2006 | A, Hendlisz; Personeni, N.; T, Delaunoit; S, Debroux; P., Flamen | |
| Tivantinib for hepatocellular carcinoma | 1-gen-2015 | Rimassa, L.; Personeni, N.; Santoro, A. | |
| Emergence of KRAS-mutation in liver metastases after an anti-EGFR treatment in patient with colorectal cancer: Are we aware of the therapeutic impact of intratumor heterogeneity? | 1-gen-2018 | Baretti, M; Personeni, N; Destro, A; Santoro, A; Rimassa, L | |
| Regorafenib for the treatment of unresectable hepatocellular carcinoma | 1-gen-2017 | Rimassa, L; Pressiani, T; Personeni, N; Santoro, A | |
| Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications | 1-gen-2016 | Personeni, N.; Baretti, M.; Bozzarelli, S.; Spaggiari, P.; Rubino, L.; Tronconi, M. C.; Fumagalli Romario, U.; Rosati, R.; Giordano, L.; Roncalli, M.; Santoro, A.; Rimassa, L. | |
| FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression : a Phase II Study | 1-gen-2015 | Personeni, N.; Rimassa, L.; Verusio, C.; Barni, S.; Rubino, L.; Bozzarelli, S.; Villa, E.; Carnaghi, C.; Tronconi, M. C.; Gerardi, C.; Galli, F.; Floriani, I.; Destro, A.; Raschioni, C.; Labianca, R.; Santoro, A. | |
| Emergence of KRAS-mutation in liver metastases after an anti-EGFR treatment in patient with colorectal cancer: are we aware of the therapeutic impact of intratumor heterogeneity? | 1-gen-2018 | Baretti, M; Personeni, N; Destro, A; Santoro, A; Rimassa, L | |
| Achievements in systhemic therapies in the pre-genomic era in metastatic breast cancer | 1-gen-2007 | M, Colozza; E, Azambuja; Personeni, N.; F, Lebrun; Mj, Piccart; F., Cardoso | |
| OncoAlert round table discussions: The global COVID-19 experience | 1-gen-2021 | Morgan, G; De Azambuja, E; Punie, K; Ades, F; Heinrich, K; Personeni, N; Rahme, R; Ferrara, R; Pels, K; Garassino, M; von Bergwelt-Baildon, M; Lopes, G; Barlesi, F; Choueiri, Tk; Burris, H; Peters, S | |
| Regorafenib for the treatment of unresectable hepatocellular carcinoma | 1-gen-2017 | Rimassa, L; Pressiani, T; Personeni, N; Santoro, A | |
| Tivantinib: a new promising mesenchymal-epithelial transition factor inhibitor in the treatment of hepatocellular carcinoma | 1-gen-2013 | Rimassa, L; Personeni, N; Simonelli, M; Santoro, A | |
| Regorafenib in hepatocellular carcinoma: latest evidence and clinical implications | 1-gen-2018 | Personeni, N; Pressiani, T; Santoro, A; Rimassa, L | |
| SYSTEMIC TREATMENT OF HCC IN SPECIAL POPULATIONS | 1-gen-2021 | Rimassa, Lorenza; Personeni, Nicola; Czauderna, Carolin; Foerster, Friedrich; Galle, Peter | |
| Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study | 1-gen-2018 | Baretti, M; Rimassa, L; Personeni, N; Giordano, L; Tronconi, Mc; Pressiani, T; Bozzarelli, S; Santoro, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Articolo su rivista71161
- 2 Contributo in volume (Capitolo ...1
- 7 Altro1
Data di pubblicazione
- In corso di stampa66
- 2020 - 202616402
- 2010 - 201922952
- 2000 - 200918285
- 1990 - 19998873
- 1980 - 19893844
- 1970 - 1979711
- 1965 - 196930
Editore
- MDPI965
- Elsevier Ltd746
- Elsevier B.V.640
- MDPI AG497
- Elsevier386
- Springer316
- John Wiley and Sons Inc314
- Multidisciplinary Digital Publish...296
- Springer Science and Business Med...288
- Elsevier Inc.261
Rivista
- ACTA BIO-MEDICA DE L'ATENEO PARMENSE933
- PLOS ONE381
- ANNALI DELLA FACOLTÀ DI MEDICINA ...348
- SCIENTIFIC REPORTS272
- AREA262
- INTERNATIONAL JOURNAL OF MOLECULA...192
- DOCTOR. OS183
- ACTA BIOMEDICA181
- NUTRIENTS179
- PHYSICAL REVIEW. B, CONDENSED MAT...169
Serie
- KEY ENGINEERING MATERIALS1
Keyword
- Humans2902
- Female1593
- Male1490
- Middle Aged900
- Adult893
- Aged757
- Animals652
- Italy585
- Medicine (all)464
- COVID-19451
Lingua
- eng42928
- ita9076
- fre232
- spa124
- ger99
- und61
- enm49
- rus41
- grc33
- por33
Accesso al fulltext
- no fulltext57852
- reserved8054
- open3765
- partially open822
- restricted667
- embargoed2
- mixed1